Interleukin 1β-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells

Journal of Cell Biology

Volumn 137, Issue 1, 1997, Pages 221-229

  Mariani, Sara M ^a   Matiba, Bernd ^a   Armandola, Elena A ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BACULOVIRUS; CELL CLONING; CELL VIABILITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INSECT; LEUKEMIA; LEUKEMIA CELL LINE; MYELOMA; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR DIAGNOSIS;

AMINO ACID CHLOROMETHYL KETONES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 1; CELL MEMBRANE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DNA FRAGMENTATION; HUMANS; JURKAT CELLS; LYMPHOMA, B-CELL; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; OLIGOPEPTIDES; POLY(ADP-RIBOSE) POLYMERASES; RABBITS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030943324     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.137.1.221     Document Type: Article

References (59)

1. Alnemri, E.S., D.J. Livingston, D.W. Nicholson, G. Salvesen, N.A. Thornberry, W.W. Wong, and J. Yuan. 1996. Human ICE/CED-3 protease nomenclature. Cell. 87:171.
2. Ashkenaz, J., and Z. Werb. 1996. Proteolysis and the biochemistry of life-or-death decisions. J. Exp. Med. 183:1947-1951.
3. Boldin, M.P., E.E. Varfolomeev, Z. Pancer, I.L. Mett, J.H. Camonis, and D. Wallach. 1995. A novel protein that interacts with the death domain of FAS/ APO-1 contains a sequence motif related to the death domain. J. Biol. Chem. 270:7795-7798.
4. Boldin, M.P., T.M. Goncharov, Y.V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell. 85:803-815.
5. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverry, S.J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, et al. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridoma. Nature (Lond.). 373:441-444.
6. Chinnaiyan, A.M., K.O. O'Rourke, M. Tewari, and V.M. Dixit. 1995. FADD, a novel death-domain containing protein interacts with the death domain of Fas and initiates apoptosis. Cell. 81:505-512.
7. Chinnaiyan, A.M., K. Orth, K.O. O'Rourke, H. Duan, G.G. Poirier, and V.M. Dixit. 1996. Molecular ordering of the cell death pathway. J. Biol. Chem. 271:4573-4577.
8. 0 cells. Cytometry. 14:883-890.
9. Darzynkiewicz, Z., S. Bruno, G. Del Bino, W. Gorzyca, M.A. Hotz, P. Lassota, and F. Traganos. 1992. Features of apoptotic cells measured by flow cytometry. Cytometry. 13:795-808.
10. Dhein, J., H. Walczak, C. Bäumler, K.M. Debatin, and P.H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature (Lond.). 373:438-441.
11. Duan, H., A.M. Chinnaiyan, P.L. Hudson, J.P. Wing, W.W. He, and V.M. Dixit. 1996. ICE-LAP3, a novel mammalian homologue of the C. elegans cell death protein ced-3 is activated during Fas and TNF-mediated apoptosis. J. Biol. Chem. 271:1621-1625.
12. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (Lond.). 375:78-81.
13. Enari, M., R.V. Talanian, W.W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (Lond.). 380:723-726.
14. Fadok, V.A., D.R. Volker, P.A. Campbell, J.J. Cohen, D.L. Bratton, and P.M. Herron. 1992. Exposure of phospatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207-2216.
15. Fernandes-Alnemri, T., A. Takahashi, R. Armstrong, J. Kress, L. Fritz, K.J. Tomaselli, L. Wang, Z. Wu, C.M. Croce, G. Salveson, et al. 1995. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res. 55: 6045-6052.
16. Fraser, A., and G. Evan. 1996. A license to kill. Cell. 85:781-784.
17. Galle, P.R., W.J. Hofmann, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P.H. Krammer, and L. Runkel. 1995. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182:1223-1230.
18. Hanabuchi, S., M. Koyonagi, A. Kawasaki, N. Shinohara, A. Matsuzawa, Y. Nishimura, Y. Kabayashi, S. Yonehara, H. Yagita, and K. Okumura. 1994. Fas and its ligand in a general mechanism of T-cell mediated cytotoxicity. Proc. Natl. Acad. Sci. USA. 91:4930-4934.
19. Henkart, P.A. 1996. ICE family proteases: mediators of all apoptotic cell death? Immunity. 4:195-196.
20. Ju, S.T., D.J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (Lond.). 373:444-448.
21. Kägi, D., F. Vignaux, B. Lederman, K. Burkin, V. Depretere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathway as major mechanisms of T-cell mediated cytotoxicity. Science (Wash. DC). 265:528-530.
22. Kischkel, F.C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P.H. Krammer, and M.E. Peter. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95) associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO (Eur. Mol. Biol. Organ.) J. 14:5579-5588.
23. Krammer, P.H., J. Dhein, H. Walczak, I. Behrman, S. Mariani, B. Matiba, M. Fath, P.T. Daniel, E. Knipping, M.O. Westendorp et al. 1994. The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 142:175-191.
24. Kuida, K., J. Lippke, G. Ku, M.W. Harding, D.J. Livingston, M. Su, and R.A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science (Wash. DC). 267:2000-2002.
25. Lazebnik, Y.A., S.H. Kaufmann, S. Desnoyers, G.G. Poirier, and W.C. Earnshaw. 1994. Cleavage of poly(ADP)-ribose polymerase by a proteinase with properties like ICE. Nature (Lond.). 371:346-347.
26. Lippke, J.A., Y. Gu, C. Sarnecki, P.R. Caron, and M.S. Su. 1996. Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J. Biol. Chem. 271:1825-1828.
27. Los, M., M. Van de Craen, L.C. Penning, H. Schenk, M. Westendorp, P.A. Bauerle, W. Droge, P.H. Krammer, W. Fiers, and K. Schulze Osthoff. 1995. Requirement of an ICE/CED3 protease for Fas/APO-1 mediated apoptosis. Nature (Lond.). 375:81-83.
28. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas ligand pathways. Nature (Lond.). 370:650-653.
29. Lynch, D.H., M.L. Watson, M.R. Alderson, P.R. Baum, R.E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C.A. Smith, K. Hunter et al. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity. 1:131-136.
30. Mariani, S.M., B. Matiba, E.A. Armandola, and P.H. Krammer. 1994. The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur. J. Immunol. 24:3119-3123.
31. Mariani, S.M., B. Matiba, C. Bäumler, and P.H. Krammer. 1995. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25:2303-2307.
32. Mariani, S.M., B. Matiba, T. Sparna, and P.H. Krammer. 1996. Expression of biologically active mouse and human CD95/Fas ligand in the baculovirus system. J. Immunol. Methods. 193:63-70.
33. Marsters, S.A., R.M. Pitti, C.J. Donahue, S. Ruppert, K.D. Bauer, and A. Ashkenazi. 1996. Activation of apoptosis by APO-2 ligand is independent of FADD but blocked by crmA. Curr. Biol. 6:750-752.
34. Martin, S., and D. Green. 1995. Protease activation during apoptosis: death by a thousand cuts? Cell. 82:349-352.
35. Martin, S.J., C.P.M. Reutelingsperger, A.J. Mc Gahon, J.A. Rader, R.C. van Schrie, D.M. LaFace, and D.R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of bcl2 and abl. J. Exp. Med. 182:1545-1553.
36. Muzio, M., A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, et al. 1996. FLICE, a novel FADD-Homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:817-827.
37. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science (Wash. DC). 267:1449-1455.
38. Nicholson, D.W., N.A. Thornberry, J.P. Vaillancourt, C.K. Ding, M. Gallant, Y. Garron, P.R. Griffin, M. Labelle, Y.A. Lazebnik, N.A. Munday, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.). 376:37-43.
39. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature (Lond.). 364:806-809.
40. Onel, K.B., C.L. Tucek-Szabo, D. Ashany, E. Lacy, J. Nikolic-Zugic, and K.B. Elkon. 1995. Expression and function of the murine CD95/FasR/APO-1 receptor in B cell ontogeny. Eur. J. Immunol. 25:2940-2947.
41. O'Reilly, D.R., L.K. Miller, and V.A. Luckow. 1994. Baculovirus expression vectors. New York Oxford University Press, New York, NY. pp. 109-204.
42. Peitsch, M., and J. Tschopp. 1995. Comparative molecular modeling of the Fas-ligand and other members of the TNF family. Mol. Immunol. 32:761-768.
43. Pitti, RM., S.A. Marsters, S. Rupper, C.J. Donahue, A. Moore, and A. Ashkenazi. 1996. Induction of apoptosis by APO-2 ligand, a new member of the TNF cytokine family. J. Biol. Chem. 271:12687-12690.
44. Rensing-Ehl, A., K. Fre, R. Flury, B. Matiba, S.M. Mariani, M. Weller, P. Aebischer, P.H. Krammer, and A. Fontana. 1995. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 25:2253-2258.
45. Rothstein, T.L., J.K.M. Wang, D.J. Panka, L.C. Foote, Z. Wang, B. Stanger, H. Cui, S. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature (Lond.). 374:163-165.
46. Rouquet, N., J.C. Pages, T. Molina, P. Briand, and V. Joulin. 1996. ICE inhibitor YVAD-cmk is a potent therapeutic agent against in vivo liver apoptosis. Curr. Biol. 6:1192-1195.
47. Shima, Y., N. Nishimoto, A. Ogata, Y. Fujii, K. Yoshizaki, and T. Kishimoto. 1995. Myeloma cells express FAS/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood. 85:757-764.
48. + T cell-mediated cytotoxicity. Immunol. 152:1127-1132.
49. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas ligand that induces apoptosis. J. Exp. Med. 179:873-879.
50. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell. 75:1169-1178.
51. Summers, M.D., and G.E. Smith. 1987. A manual of methods for baculovirus vectors and insect cell culture procedures. Texas Agric. Exp. Stat. Bull. No. 1555.
52. Takahashi, A., and W.C. Earnshaw. 1996. ICE-related proteases in apoptosis. Curr. Biol. 6:50-55.
53. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in gld mice, caused by a point mutation in the Fas ligand. Cell. 76:969-976.
54. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO (Eur. Mol. Biol. Organ.) J. 14:1129-1135.
55. Tewari, M., and V.M. Dixit. 1995. Fas-and TNF-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270:3255-3260.
56. Tewari, M., L.T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D.R. Beidler, G.G. Poirier, G.S. Salveson, and V.M. Dixit. 1995. YAMA/CPP32β, a mammalian homolog of CDE-3 is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP)-ribose polymerase. Cell. 81:801-809.
57. Thornberry, N.C., D. Miller, and D. Nicholson. 1995. Interleukin-1β converting enzyme and related proteases as potential targets in inflammatory apoptosis. Perspectives in Drug Discovery and Design. 2:389-399.
58. Wiley, S.R., K. Schooley, P.J. Smolak, W.S. Din, C.P. Huang, J.K. Nicholl, G.R. Sutherland, T. Davis Smith, C. Rauch, C.A. Smith, et al. 1995. Identification and characterization of a new member of the TNF family thai induces apoptosis. Immunity. 3:673-682.
59. Wyllie, A.H., and R.G. Morris. 1982. Hormone-induced cell death: purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am. J. Path. 109:78-87.